Ignite Creation Date:
2024-05-06 @ 2:59 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04499157
Status:
RECRUITING
Last Update Posted:
2023-02-08
First Post:
2020-07-29
Brief Title:
Effect of MEMOPTIC on Visual Field of Patients Followed for a Chronic Open-angle Glaucoma
Sponsor:
Centre Hospitalier Universitaire Amiens
Organization:
Centre Hospitalier Universitaire Amiens
Study Overview
Official Title:
Effect of MEMOPTIC on Visual Field of Patients Followed for a Chronic Open-angle Glaucoma
Status:
RECRUITING
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MEMO-GCAO
Brief Summary:
Open-angle glaucoma is a degeneration of the optic nerve highlighted by campimetric alterations and wose only current therapeutic target is the lowering of the intra-ocular pressure using eye drops surgery or laser MEMOPTIC is a tablet combining citicoline magnesium and Gingko biloba which have a neuroprotective effect already used in neurodegenerative diseases such as Alzheimers disease for example Citicoline has also shown several promising results in ophthalmological diseases glaucoma amblyopia or more recently in ischemic optic neuropathies The citicoline used in eye drops NEURODROP has already shown results on the preservation of the vision of glaucomatous patients
The purpose of this project is to determine if MEMOPTIC can have an effect in addition to the conventional treatments in the preservation of vision of patients treated for an open-angle glaucoma
The purpose of this project is to determine if MEMOPTIC can have an effect in addition to the conventional treatments in the preservation of vision of patients treated for an open-angle glaucoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None